Abstract
The knowledge of interactions between different molecules is undoubtedly the driving force of all contemporary biomedical and biological sciences. Chemical biology/biological chemistry has become an important multidisciplinary bridge connecting the perspectives of chemistry and biology to the study of small molecules/peptidomimetics and their interactions in biological systems. Advances in structural biology research, in particular linking atomic structure to molecular properties and cellular context, are essential for the sophisticated design of new medicines that exhibit a high degree of druggability and very importantly, druglikeness. The authors of this contribution are outstanding scientists in the field who provided a brief overview of their work, which is arranged from in silico investigation through the characterization of interactions of compounds with biomolecules to bioactive materials.
Funding Information
  • Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (2/0103/22)
  • Engineering and Physical Sciences Research Council (EP/S025243/1)
  • Wellcome Trust (100209/Z/12/Z, 223733/Z/21)
  • Biotechnology and Biological Sciences Research Council (BB/V018523/1)
  • MRC (MR/V03958X/1)
  • CERM/CIRMMP centre of Instruct-ERIC
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Fondazione Cassa di Risparmio di Firenze
  • HPC facility at Slovak Academy of Sciences (ITMS 26230120002, ITMS 26210120002)
  • Polish National Science Center NCN (UMO-2018/31/B/NZ7/02122)
  • Department of Inorganic Chemistry, Palacký University
  • National Science Centre (Poland) (PW-2004-105)
  • Fundacja na rzecz Nauki Polskiej (POIR.04.04.00-00-16D7/18)

This publication has 119 references indexed in Scilit: